Publication | Open Access
Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus.
31
Citations
25
References
1988
Year
ImmunologyHiv-1 IsolatesHuman Immunodeficiency VirusImmunotherapySimian Immunodeficiency VirusMouse Monoclonal AntibodiesHuman RetrovirusAntibody EngineeringPrimary ImmunodeficiencyAllergyVirologyChronic Viral InfectionHivAids PathogenesisAntiviral TherapyAntiviral ResponseMonoclonal AntibodiesMedicineViral ImmunitySiv Isolates
Four mouse monoclonal antibodies were developed after immunization with one human immunodeficiency virus (HIV) type 2 isolate and were tested for reactivity with different HIV-1, HIV-2, and simian immunodeficiency virus (SIV) isolates in an immunofluorescence assay and by immunological blot analysis. One of them, an anti-capsid (p24) antibody, called R1C7, reacted with all HIV-1, HIV-2, and SIV isolates tested, thus identifying an epitope shared by all HIV and SIV. Another anti-capsid antibody, named A4F6, reacted with three HIV-2 isolates (HIV-2NIH-Z, LAV-2Rod, and LK001 ST9), some SIV isolates (STLV-IIIAGM, SIV-251, and SIV-309), but no HIV-1 isolates. Two anti-matrix (p16) antibodies, named R5C4 and R5F6, reacted strongly only with the HIV-2 isolates. The use of these monoclonal antibodies for rapid discrimination and identification of acquired immunodeficiency syndrome-related retroviruses is discussed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1